- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Nasus Pharma Ltd (NSRX)
Assess today's live Nasus Pharma Ltd (NSRX) share price, performance and insights using our live NYSE: NSRX stock exchange data.
Analyse the historical data and Nasus Pharma Ltd share price performance charts on this page. Our technical summary section provides analysis on Nasus Pharma share price buy/sell indicators using real-time data (or discuss the Nasus Pharma (NSRX) stock price today with other investors in the Nasus Pharma NYSE share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NYSE NSRX share price (ISIN: IL0012181553) to enhance your trading decisions with our free investment tools and resources.
What Is the Nasus Pharma Ltd Share Price Today?
The Nasus Pharma share price today is 6.17.
What Is the Stock Symbol for Nasus Pharma Ltd
The stock symbol (or 'ticker') for Nasus Pharma Ltd is "NSRX."
What Stock Exchange Does Nasus Pharma Ltd Trade On?
Nasus Pharma Ltd is listed and trades on the NYSE stock exchange.
Is Nasus Pharma Ltd a Good Stock to Buy?
Determining whether Nasus Pharma Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Nasus Pharma Ltd share price performance charts on this page. Our technical summary section provides analysis on Nasus Pharma share price buy/sell indicators using real-time data (or discuss the Nasus Pharma (NSRX) stock price today with other investors in the Nasus Pharma NYSE share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NYSE NSRX share price (ISIN: IL0012181553) to enhance your trading decisions with our free investment tools and resources.
What Is the Nasus Pharma Ltd Share Price Today?
The Nasus Pharma share price today is 6.17.
What Is the Stock Symbol for Nasus Pharma Ltd
The stock symbol (or 'ticker') for Nasus Pharma Ltd is "NSRX."
What Stock Exchange Does Nasus Pharma Ltd Trade On?
Nasus Pharma Ltd is listed and trades on the NYSE stock exchange.
Is Nasus Pharma Ltd a Good Stock to Buy?
Determining whether Nasus Pharma Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
NYSE
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
5.50
6.39
52 wk Range
5.42
9.99
Unusual Post-Market activity
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
5.506.39
52 wk Range
5.429.99
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
NSRX Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
20.50
Upside
+232.25%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Short term obligations exceed liquid assets
- Nasus Pharma receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Nasus Pharma receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Buy
Moving Averages
Neutral
Nasus Pharma Company Profile
Nasus Pharma Ltd. operates as a clinical-stage specialty pharmaceutical company focused on the development of intranasal drugs to treat emergency medical conditions. The company offers Powder-Based Intranasal (PBI) products to address acute medical conditions and public health threats. The company’s products include NS002, Intranasal Epinephrine for assisting in severe allergic reaction emergency situations and NS001, an Intranasal Naloxone powder nasal spray for the treatment of opioid overdose. Nasus Pharma Ltd. was incorporated in 2019 and is based in Tel Aviv-Yafo, Israel.
Compare NSRX to Peers and Sector
Metrics to compare | NSRX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipNSRXPeersSector | |
|---|---|---|---|---|
P/E Ratio | −26.8x | −0.5x | −0.6x | |
PEG Ratio | 4.30 | −0.01 | 0.00 | |
Price/Book | −11.6x | 0.6x | 2.6x | |
Price / LTM Sales | - | 2.4x | 3.3x | |
Upside (Analyst Target) | 272.7% | 580.7% | 44.6% | |
Fair Value Upside | Unlock | 23.2% | 6.0% | Unlock |
Analyst Ratings
2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 20.50
(+232.25% Upside)
Earnings
Latest Release
Dec 03, 2025
EPS / Forecast
-0.14 / --
Revenue / Forecast
-- / --
People Also Watch
FAQ
What Is the Nasus Pharma (NSRX) Share Price Today?
The live Nasus Pharma share price today is 6.17
What Stock Exchange Does Nasus Pharma (NSRX) Trade On?
Nasus Pharma is listed and trades on the New York Stock Exchange.
What Is the Ticker (Stock Symbol) for Nasus Pharma?
The stock symbol (also called a 'ticker') for Nasus Pharma is "NSRX."
What Is the Current Nasus Pharma Market Cap?
As of today, Nasus Pharma market capitalisation is 49.85M.
What Is Nasus Pharma's (NSRX) Earnings Per Share (TTM)?
The Nasus Pharma EPS is currently -0.26 (Trailing Twelve Months).
When Is the Next Nasus Pharma Earnings Date?
Nasus Pharma's next earnings report will be released on 25 Feb 2026.
Is NSRX a Buy or Sell From a Technical Analyst Perspective?
Based on today's Nasus Pharma moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Nasus Pharma Stock Split?
Nasus Pharma has split 0 times. (See the NSRX stock split history page for full effective split date and price information.)
How Many Employees Does Nasus Pharma Have?
Nasus Pharma has 2 employees.
What is the current trading status of Nasus Pharma (NSRX)?
As of 03 Feb 2026, Nasus Pharma (NSRX) is trading at a price of 6.17, with a previous close of 5.50. The stock has fluctuated within a day range of 5.50 to 6.39, while its 52-week range spans from 5.42 to 9.99.
What Is Nasus Pharma (NSRX) Price Target According to Analysts?
The average 12-month price target for Nasus Pharma is USD20.50, with a high estimate of USD22 and a low estimate of USD19. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +232.25% Upside potential.
What Is the NSRX After Hours Price?
NSRX's last after hours stock price is 5.61, the stock has decreased by -0.56, or -9.08%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.